Skip to main content
F

Faraday

Faraday Bio provides a microfluidic platform that replicates standard electrophoretic separations while capturing each resolved protein band on‑chip for direct extraction. The isolated bands can be fed into downstream structural and functional assays, eliminating the need for separate orthogonal tests and streamlining biopharma protein analysis workflows.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Traditional electrophoretic separations visualize protein bands but do not provide access to the material within each band, preventing direct structural and functional analysis of individual proteoforms. This forces researchers to perform separate orthogonal assays, increasing time, cost, and analytical risk.

Solution

Faraday Bio offers a microfluidic platform that reproduces standard electrophoretic methods while integrating on‑chip capture of each resolved protein band. The captured bands are recovered as assay‑ready material, enabling downstream structural and functional characterization without re‑running separations. By preserving the original high‑resolution separation and delivering isolated variants, the system eliminates the need for multiple parallel assays and streamlines workflow integration. The technology supports any electrophoretic technique, providing biopharma researchers with a seamless bridge from separation to comprehensive analysis.

Target Audience

Primary customers are biopharmaceutical R&D and analytical teams that need high‑resolution protein separations combined with immediate access to individual proteoforms for characterization, as well as contract research organizations supporting biologics development.

Features

  • Proprietary microfluidic cartridge that performs conventional electrophoresis (e.g., capillary, slab‑gel) with high resolution
  • Integrated on‑chip capture modules that isolate each protein band for direct extraction
  • Compatibility with downstream structural (e.g., mass spectrometry, NMR) and functional (e.g., activity, binding) assays
  • Reproducible, scalable operation suitable for routine biopharmaceutical development and quality control
  • Maintains original separation fidelity, ensuring “what you see is what you get” for analytical decision‑making
This profile is AI-generated and may contain inaccuracies.